|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IMUX |
Immunic Inc |
Director |
|
2015-09-10 |
4 |
B |
$3.05 |
$18,293 |
D/D |
6,000 |
39,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,131 |
40,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-04 |
4 |
AS |
$107.71 |
$98,660 |
I/I |
(916) |
42,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-05 |
4 |
S |
$113.70 |
$1,137,016 |
I/I |
(10,000) |
42,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-10 |
4 |
OE |
$6.46 |
$231,824 |
D/D |
35,886 |
42,581 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-03 |
4 |
S |
$85.33 |
$256,002 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-10 |
4 |
S |
$87.00 |
$348,000 |
I/I |
(4,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-25 |
4 |
AS |
$90.00 |
$180,000 |
I/I |
(2,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-10 |
4 |
AS |
$95.00 |
$190,000 |
I/I |
(2,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-24 |
4 |
AS |
$88.73 |
$266,193 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-02 |
4 |
AS |
$107.96 |
$323,893 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-04 |
4 |
OE |
$9.86 |
$4,930 |
I/I |
500 |
43,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-31 |
4 |
OE |
$12.99 |
$38,970 |
I/I |
3,000 |
43,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-06-04 |
4 |
OE |
$60.72 |
$607,194 |
I/I |
10,000 |
43,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-06-05 |
4 |
OE |
$58.68 |
$593,406 |
I/I |
10,000 |
43,740 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2018-09-13 |
4 |
S |
$0.47 |
$9,400 |
D/D |
(20,000) |
45,119 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-25 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
45,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-10 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
45,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
45,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
OE |
$12.99 |
$324,750 |
I/I |
25,000 |
45,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-10-10 |
4 |
AS |
$66.76 |
$200,291 |
I/I |
(3,000) |
45,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-10-16 |
4 |
AS |
$67.73 |
$135,450 |
I/I |
(2,000) |
45,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-10-31 |
4 |
AS |
$62.72 |
$627,155 |
I/I |
(10,000) |
45,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-11-05 |
4 |
AS |
$62.36 |
$311,779 |
I/I |
(5,000) |
45,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-22 |
4 |
AS |
$56.88 |
$56,876 |
I/I |
(1,000) |
46,195 |
0 |
- |
|
853 Records found
|
|
Page 9 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|